3D Systems Corp - DDD STOCK NEWS

3D Systems Corporation (NYSE:DDD) reported a Q4 2022 revenue of $132,732, down 12.0% year-over-year, influenced by weakness in the dental orthodontics market. The full-year revenue was $538,031, reflecting a 12.6% decline from 2021. The company posted a net loss of $25,553 in Q4, totaling $122,711 for the year, leading to diluted losses of $0.20 and $0.96 per share respectively. Despite challenges, the company anticipates mid-single digit revenue growth in 2023, supported by strong performance in Industrial and Healthcare segments. The company projects Adjusted EBITDA to break even or better and maintains a robust cash position of $568,737.

3D Systems (NYSE: DDD) announced a restructuring initiative aimed at enhancing operational efficiencies. This initiative includes optimizing European metal printer operations and streamlining software organization, expected to cut operating expenses by $2.5 million to $3.5 million in 2023, and annual savings of $5.5 million to $7.0 million from 2024 onwards. The engineering and manufacturing consolidation of metal printers aims to improve product introduction cycles. Additionally, the merger of software development structures will yield cost savings through integration. Activities will commence immediately and conclude by mid-2023, reinforcing 3D Systems' commitment to operational excellence.

3D Systems (NYSE: DDD) announced that BWT Alpine F1 Team has purchased four SLA 750 3D printing systems to enhance productivity and part quality in its operations. This acquisition allows the team to produce 25,000 parts annually, significantly improving wind tunnel testing models using 3D Systems’ Accura Composite PIV material. The SLA 750 systems were chosen after rigorous testing, demonstrating superior print quality and efficiency. BWT Alpine F1 Team highlighted the systems' ability to reduce build times while maintaining high geometric accuracy and surface quality, ultimately accelerating innovation and design iteration.

3D Systems (NYSE: DDD) has announced the launch of its Regenerative Tissue Program, focusing on developing bioprinted human tissues for various surgical applications. The program leverages the company’s expertise in solid organ development and advanced bioprinting technology. The initial product targets patient-specific regenerative breast tissue (RBT™), addressing the growing need for long-term solutions for breast reconstruction among cancer survivors. With a focus on high-resolution scaffolds and patient-derived cells, 3D Systems aims to improve surgical outcomes and elevate patient experiences. This program builds on over a decade of collaboration with surgeons and extensive research in tissue regeneration.

3D Systems has launched the ProJet MJP 2500W Plus, a cutting-edge 3D printer tailored for the jewelry manufacturing sector, valued at $25 billion. This innovative machine boasts a 2x improvement in vertical resolution and enhances throughput by 25%, allowing for faster production of 100% wax casting patterns. The printer minimizes the need for costly manual polishing, reducing precious metal waste and increasing profitability for users. Designed for high-quality and complex jewelry designs, it supports rapid design iterations and mass customization, aligning with the growing demand in the jewelry additive manufacturing market.

3D Systems (NYSE: DDD) appointed Dr. Rebekah Gee to its Medical Advisory Board, effective March 1, 2023. Dr. Gee, a public health policy expert and former Secretary of the Louisiana Department of Health, brings extensive experience in healthcare innovation and policy implementation. The advisory board, established in May 2022, aims to guide the company's regenerative medicine initiatives, focusing on advanced 3D printing technologies for human organ production and related applications. Dr. Gee's insights will be pivotal for navigating healthcare delivery challenges, including patient insurance and reimbursement issues, supporting 3D Systems' strategic goals in the medical sector.

3D Systems (NYSE:DDD) has announced the release date for its fourth quarter and full year 2022 financial results, scheduled for February 28, 2023. A conference call to discuss these results will take place on March 1, 2023, at 8:30 a.m. Eastern Time. Investors can access the call via telephone or listen to a live webcast on the company's investor relations website. 3D Systems has over 35 years of experience in 3D printing, providing innovative solutions across various industries including healthcare and aerospace. For more details, visit their investor relations page.

3D Systems (NYSE: DDD) has formed a three-year technical partnership with Stewart-Haas Racing, aimed at enhancing the racing team's engineering capabilities. Utilizing 3D Systems' ProX 800 and Figure 4 printers, the partnership will facilitate rapid design and production of crucial components, improving the speed and performance of racecars. This collaboration allows for quicker iteration on designs and prototyping, essential for attaining a competitive edge. The partnership officially commences with the NASCAR Xfinity Series race at Daytona on February 18, 2023.

3D Systems (NYSE:DDD) announced that rms Company, a leading medical device manufacturer, has integrated the DMP Flex 350 Dual into its production process. This addition increases productivity by up to 50%, enhancing rms' powder to package capabilities and expanding the range of implants produced. With over 30 DMP printers, rms is positioned to innovate and streamline the manufacturing of high-quality, tight-tolerance medical devices, particularly titanium implants. The DMP Flex 350 Dual's dual-laser system allows for greater efficiency without compromising precision, aligning with current industry demands.